Comparison of Postoperative Analgesic Effectiveness of Superficial and Deep Serratus Plane Blocks for Mastectomy
Launched by TC ERCIYES UNIVERSITY · May 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two different methods of pain relief for women undergoing mastectomy, a type of breast surgery. The study is focused on comparing the effectiveness of superficial and deep serratus plane blocks, which are special techniques used to numb pain after surgery. The goal is to manage pain effectively right after the operation to help improve recovery and prevent long-term pain problems.
To participate in this study, women aged between 18 and 75 who are scheduled for a mastectomy and are in generally good health (American Society of Anesthesiologists Class I-II) may be eligible. However, individuals who are planning to have surgery on both breasts, have had previous breast surgeries, or have specific medical conditions such as chronic pain, psychiatric disorders, or allergies to local anesthetics will not be able to participate. If you join the trial, you can expect to receive one of the two pain relief methods after your surgery and be monitored for how well it works in managing your pain. This research aims to improve how we treat pain following breast surgery, making recovery easier for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • patients who will undergo mastectomy surgery
- • patients who agreed to participate in the study
- • ASA I-II patients
- Exclusion Criteria:
- • Patients planned for bilateral breast surgery
- • Patients who have had previous breast surgery
- • Patients with existing neuropathic pain or receiving treatment for neuropathic pain
- • Patients with psychiatric disorders
- • Patients with opioid addiction
- • Patients allergic to local anesthetics
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, Talas, Turkey
Patients applied
Trial Officials
Ayşe Ülgey, MD
Study Director
TC Erciyes University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported